| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing1@energy-chemical.com |
| Products Intro: |
Product Name:(+/-)-(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide >=97%
CAS:162626-99-5
Purity:97% Package:10mg Remarks:NULL
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Email: |
ordercn@merckgroup.com |
| Products Intro: |
Product Name:(±)-(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide
CAS:162626-99-5
|
NOR 4 manufacturers
- NOR 4
-
- $1.10 / 1g
-
2025-04-17
- CAS:162626-99-5
- Min. Order: 1g
- Purity: 99.0% min
- Supply Ability: 100 tons min
|
| Product Name: | NOR 4 | | Synonyms: | NOR 4;(+or-)-N-{(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexene-1-yl}-3-pyridinecarboxamide;N-{(E)-4-Ethyl-3-[(Z)-hydroxyimino]-5-nitro-3-hexen-1-yl}-3-pyridine carbox;(±)-{(E)-4-Ethyl-2-[(Z)-Hydroxyimino]-5-nitro-3-hexene-1-yl}-pyridinecarboxamide;N-((2Z,3E)-4-Ethyl-2-(hydroxyimino)-5-nitrohex-3-en-1-yl)nicotinamide;(+/-)-{(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexene-1-yl}-pyridinecarboxamide (NOR 4);3-Pyridinecarboxamide, N-[(3E)-4-ethyl-2-[(2Z)-hydroxyimino]-5-nitro-3-hexen-1-yl]-;(+/-)-(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexen-1-yl-nicotinamide >=97% | | CAS: | 162626-99-5 | | MF: | C14H18N4O4 | | MW: | 306.32 | | EINECS: | | | Product Categories: | | | Mol File: | 162626-99-5.mol |  |
| | NOR 4 Chemical Properties |
| Boiling point | 600.8±55.0 °C(Predicted) | | density | 1.26±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | pka | 6?+-.0.10(Predicted) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 |
| | NOR 4 Usage And Synthesis |
| Uses | NO donor; releases nitric oxide spontaneously in a rate-controlled manner. Half-life in solution = 60min. |
| | NOR 4 Preparation Products And Raw materials |
|
|
Tag:NOR 4(162626-99-5)
Related Product Information
|
|
3-(cyclopentyloxy)-19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yn-17-o
17beta-hydroxy-17alpha-ethyl-19-nor-4-androsten
(+/-)-11-NOR-9-CARBOXY-DELTA9-THC
19-nor-9-beta,10-alpha-lanosta-1,5,23-triene-3,11,22-trione,9-methyl-2,16,20,
19-Nor-ethinyl-5,10-testosterone,17-Hydroxy-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one,17-hydroxy-19-nor-17alpha-pregn-5(10)-en-20-yn-3-o
19-Nor-17alpha-pregn-4-en-20-yn-3beta,17-diol diacetate,19-nor-17-alpha-pregn-4-en-20-yne-3-beta,17-diol,diacetat
17beta-hydroxy-19-nor-4-androsten-3-on
racemicdesoxy-nor-ephedrin
17-beta-hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-on
(-)-11-NOR-9-CARBOXY-DELTA9-THC
19-nor-17-alpha-pregn-4-en-20-yn-17-o
19-nor-17-alpha-ethynylandrosten-17-beta-ol-3-on
19-nor-9-beta,10-alpha-lanosta-1,5,23-triene-3,11,22-trione,2,16-alpha,20,25-
17-acetoxy-19-nor-17-alpha-pregn-4-en-20-yn-3-o
19-nor-17α-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy
17-alpha-acetoxy-6-methyl-19-nor-4,6-pregnadiene-3,20-dion
Mesuximide, M(nor-)
19-nor-17-alpha-pregn-4-en-20-yn-3-one,17-hydroxy-,oxime,acetat
|